CENESTIN از شرکت ASPEN

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CENESTIN از شرکت ASPEN

New Drug Application (NDA): 020992

Company: ASPEN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CENESTIN ESTROGENS, CONJUGATED SYNTHETIC A 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CENESTIN ESTROGENS, CONJUGATED SYNTHETIC A 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CENESTIN ESTROGENS, CONJUGATED SYNTHETIC A 0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CENESTIN ESTROGENS, CONJUGATED SYNTHETIC A 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CENESTIN ESTROGENS, CONJUGATED SYNTHETIC A 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/24/1999 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20992lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20992ltr.htm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20992.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/30/2020 SUPPL-39 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020992s038s039lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020992Orig1s038, s039ltr.pdf

11/30/2020 SUPPL-38 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020992s038s039lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020992Orig1s038, s039ltr.pdf

11/01/2017 SUPPL-37 Labeling-Package Insert

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020992s037lbl.pdf

03/20/2015 SUPPL-34 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020992s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020992Orig1s034ltr.pdf

10/28/2004 SUPPL-26 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20992s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20992s026ltr.pdf

01/28/2004 SUPPL-24 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20992slr024ltr.pdf

11/05/2002 SUPPL-23 Manufacturing (CMC)-Control

Label is not available on this site.

10/18/2002 SUPPL-22 Manufacturing (CMC)

Label is not available on this site.

02/05/2004 SUPPL-21 Efficacy-New Dosing Regimen

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20992se2-021_cenestin_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20992se2-021ltr.pdf

04/29/2002 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

03/05/2002 SUPPL-19 Manufacturing (CMC)-Control

Label is not available on this site.

02/08/2002 SUPPL-18 Manufacturing (CMC)-Control

Label is not available on this site.

02/08/2002 SUPPL-17 Manufacturing (CMC)-Control

Label is not available on this site.

06/21/2002 SUPPL-16 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20992s16lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20992s016LTR.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020992_S016_CENESTINTOC.cfm

09/05/2001 SUPPL-15 Manufacturing (CMC)-Control

Label is not available on this site.

09/10/2001 SUPPL-14 Manufacturing (CMC)-Control

Label is not available on this site.

09/05/2001 SUPPL-13 Manufacturing (CMC)-Control

Label is not available on this site.

07/20/2001 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

02/22/2002 SUPPL-11 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20992s11ltr.pdf

08/09/2000 SUPPL-9 Manufacturing (CMC)-Control

Label is not available on this site.

01/27/2000 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

03/13/2000 SUPPL-6 Manufacturing (CMC)-Formulation

Label is not available on this site.

01/07/2000 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

11/08/1999 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

11/12/1999 SUPPL-3 Manufacturing (CMC)-Control

Label is not available on this site.

11/02/1999 SUPPL-2 Manufacturing (CMC)-Packaging

Label is not available on this site.

09/07/1999 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/30/2020 SUPPL-39

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020992s038s039lbl.pdf
11/30/2020 SUPPL-38

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020992s038s039lbl.pdf
11/01/2017 SUPPL-37

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020992s037lbl.pdf
03/20/2015 SUPPL-34

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020992s034lbl.pdf
10/28/2004 SUPPL-26

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20992s026lbl.pdf
02/05/2004 SUPPL-21

Efficacy-New Dosing Regimen

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20992se2-021_cenestin_lbl.pdf
06/21/2002 SUPPL-16

Efficacy-New Indication

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20992s16lbl.pdf
03/24/1999 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20992lbl.pdf
بخوانید  COLESEVELAM HYDROCHLORIDE از شرکت WATSON LABS INC
به بالای صفحه بردن